Sfa Therapeutics
SFA Therapeutics is a clinical stage start-up biotech company with a platform technology based on Nobel Prize winning research. This patented and proprietary platform is based on the immuno-modulation of inflammatory factors through innate T-Regulatory (Treg) cell differentiation. The technology is licensed from and supported by research at Temple University in Philadelphia. The result is a unique native immunotherapy platform with activity currently being investigated in cancer, liver, and auto-immune disease.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Sfa Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
Showing 1 of 5 verified contacts
Top roles at Sfa Therapeutics
2 distinct titles indexed · top 2 shown.
- 1chief executive officer
- 1scientific collaborator
Sign up to unlock all 5 contacts at Sfa Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Sfa Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.